Current status of beta‐thalassemia and its treatment strategies - Ali - 2021 - Molecular Genetics & Genomic Medicine - Wiley Online Library
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia
Novel genetic therapeutic approaches for modulating the severity of β‑ thalassemia (Review)
Frontiers | The Future of Gene Therapy for Transfusion-Dependent Beta- Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells
Thalassaemia - The Lancet
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
Gene Therapy For Beta-Thalassemia: Updated Perspectives | TACG
Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley
Pathophysiology and treatment of patients with... | F1000Research
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
Β-Thalassemias | NEJM
Beta Thalassemia: Practice Essentials, Etiology, Epidemiology
Diseases | Free Full-Text | Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis
Full article: Revisiting beta thalassemia intermedia: past, present, and future prospects
Antioxidants as Complementary Medication in Thalassemia | IntechOpen
Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine | Scientific Reports
Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu
2021 update on clinical trials in β‐thalassemia - Musallam - 2021 - American Journal of Hematology - Wiley Online Library
Current and future alternative therapies for beta-thalassemia major - ScienceDirect